In conclusion, several CTAs, such as MAGEA3, PLU-1, or DKKL, may serve as biomarkers of CRC, and since their expression correlates with advanced stages of the disease, they are of prognostic relevance. The gene discussed is MAGEA3; the disease is colorectal carcinoma.